Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

HMPR, CELH, SPEX, PTSH, PWRM - Market News From DrStockPick.com!

drstock-2-3

signup3m


power3

Power3 Medical Products, Inc. (OTC.BB:PWRM) a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, recently delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (NASDAQ:ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro®, Power3's diagnostic test, and focused on Power3's Alzheimer's disease blood serum biomarkers, test and clinical validation trials.

"In preparation for commercialization, our objective at this meeting was to show how Power3's protein biomarkers and blood tests provide superior solutions for diagnosis and drug response to improve the treatment of Alzheimer's disease," said Dr. Ira L. Goldknopf, Power3's President and Chief Scientific Officer. "It was gratifying to receive substantial attention to our posters from representatives of major pharma and clinical research institutions from around the world. They expressed surprise and enthusiasm for our findings, especially those relating to the methods by which Power3's protein biomarkers indicate how patients respond to treatment with the three major anti-dementia drugs."

"We are pleased that our blood tests specifically diagnose Alzheimer's in patients, both pre- and post-treatment," said Helen R. Park, MS, Chief Executive Officer of Power3, "and that our scientific collaborators, Dr. Marwan Sabbagh, Medical and Scientific Director of the Banner Sun Health Medical Research Institute, and Dr. Lourdes R. Bosquez, President of the Woodlands Behavioral Institute, Inc., presented along with us at the meeting in Hawaii."

*******************************************************

ptsh_logo

PTS, Inc. (OTC.BB:PTSH) announced that through its ThinLine division it has signed a 3 year IT Services deal with United Power.

United Power is acknowledged experts on the resale of products especially suited for medium voltage power distribution, in addition to providing a wide portfolio of products for other aspect of the electrical utility business. United Power has been serving electrical utility Customers within Georgia continuously since 1976. They have developed a reputation for customer sensitivity, fair dealing and exceptional quality during this time.

United Power required an IT solution that would allow them to contact one source for all of their IT needs.

"United Power is a well-established and quality company that has been a leader in their field for decades" stated Raj Kalra CEO of PTS. "They were looking for a one stop shop that would be able to handle their IT, disaster recovery and hardware needs without making more than one phone call. ThinLine's managed IT solution was designed for this task. We look forward to working with the team at United Power and I am always excited to add a quality client to our growing portfolio of managed It customers," added Raj Kalra.

*******************************************************

Spherix Inc. (Nasdaq:SPEX) an innovator in biotechnology for therapy in diabetes and the metabolic syndrome, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, reported results for the three months ended September 30, 2010. Announced exploration of D-tagatose as a treatment for high triglycerides, a risk factor for atherosclerosis, myocardial infraction, and stroke. Acquired development and marketing rights for D-tagatose for triglycerides from the University of Kentucky Research Foundation. Goal of the triglycerides program is to explore drug mechanism of action, investigate proof of concept and analyze the formulation, dose and dosing regimen appropriate for the triglyceride market segment. Announced efficacy results of the Phase 3 trial for the treatment of Type 2 diabetes in October 2010which showed a statistically significant drop in HbA1c levels in mild diabetics.

Spherix Incorporated, together with its subsidiaries, operates as a scientific research company. It is developing D-tagatose that is in Phase 3 clinical trial for the treatment of type 2 diabetes. The company also provides scientific and strategic support for suppliers, manufacturers, distributors, and retailers of conventional foods.

*******************************************************

Celsius Holdings, Inc. (Nasdaq:CELH) the creator and marketer of Celsius®, Your Ultimate Fitness Partner™, announced that the company received a letter from The NASDAQ Stock Market indicating that the company is not in compliance with a NASDAQ listing rule, which requires a minimum stockholders’ equity of $2.5 million for continued listing. As reported in the company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2010, the company’s stockholders’ equity as of such date was $1,954,873. The company also does not currently meet the alternative criteria for continued listing under the rule. In accordance with NASDAQ rules, the company has been provided with a 45 calendar day grace period or until December 30, 2010, to submit a plan to regain compliance. If such plan is accepted, NASDAQ may grant the Company an extension of up to 180 calendar days or until May 14, 2011, to regain compliance.

Celsius Holdings, Inc., together with its subsidiaries, engages in the development, marketing, sale, and distribution of functional calorie-burning beverages in the United States and internationally. It provides Celsius, a calorie burning beverage, which comprises ingredients and supplements, such as green tea, ginger, calcium, chromium, and B and C vitamins, as well as sucralose.

*******************************************************

Hampton Roads Bankshares Inc. (Nasdaq:HMPR) the holding company for Bank of Hampton Roads and Shore Bank, announced on November 19, 2010 that it received a letter (the “Notification Letter”) from The NASDAQ Stock Market (”NASDAQ”) notifying the Company that it no longer meets NASDAQ’s continued listing requirement under Listing Rule 5450(a)(1) (the “Bid Price Rule”). The Notification Letter states that the minimum bid price of the Company’s common stock has traded below $1.00 per share for 30 consecutive business days and that the Company is therefore not in compliance with the Bid Price Rule. The Notification Letter has no effect at this time on the listing of the Company’s common stock on the NASDAQ Global Select Market and the Company’s common stock will continue to trade on the NASDAQ Global Select Market under the symbol “HMPR.”

Hampton Roads Bankshares, Inc. operates as the holding company for Bank of Hampton Roads (BOHR) and Shore Bank that provide community and commercial banking services primarily to individuals and businesses. The company offers a range of interest-bearing and non-interest-bearing deposit accounts, including commercial and retail checking accounts, money market accounts, individual retirement accounts, regular interest bearing savings accounts, and certificates of deposit.

*******************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

drstbc

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.

Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (OTC:PWRM).

Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for (thirty) days of advertising for PTS Inc.(OTCPK:PTSH)